NVCR PE Ratio & Valuation, Is NVCR Overvalued

Historical Valuation

Novocure Ltd (NVCR) is now in the Undervalued zone, suggesting that its current forward PS ratio of 2.14 is considered Undervalued compared with the five-year average of 8.19. The fair price of Novocure Ltd (NVCR) is between 86.79 to 166.21 according to relative valuation method. Compared to the current price of 11.61 USD , Novocure Ltd By Undervalued By 86.62%.

Relative Value

Fair Zone

86.79-166.21

Current Price：11.61

86.62%

Undervalued

P/E

EV/EBITDA

EV/EBIT

P/S

P/OCF

P/FCF

Trailing

Forward

Unlock 5-Year Valuation Change

Is Novocure Ltd (NVCR) at a historical peak or a rare bargain? Access the full 5-year trend to find out.

Unlock Now

Novocure Ltd (NVCR) has a current Price-to-Book (P/B) ratio of 4.30. Compared to its 3-year average P/B ratio of 6.24, the current P/B ratio is approximately -31.07% higher. Relative to its 5-year average P/B ratio of 14.78, the current P/B ratio is about -70.87% higher. Novocure Ltd (NVCR) has a Forward Free Cash Flow (FCF) yield of approximately -4.44%. Compared to its 3-year average FCF yield of -4.29%, the current FCF yield is approximately 3.49% lower. Relative to its 5-year average FCF yield of -2.26%, the current FCF yield is about 96.27% lower.

Competitors Valuation Multiple

AI Analysis

The average P/S ratio for NVCR competitors is 64.55, providing a benchmark for relative valuation. Novocure Ltd Corp (NVCR.O) exhibits a P/S ratio of 2.14, which is -96.68% above the industry average. Given its robust revenue growth of 8.11%, this premium appears unsustainable.

P/E

P/S

EV/EBITDA

EV/EBIT

Earnings Growth

Market Cap

Performance Decomposition

AI Analysis

Market capitalization of NVCR increased by 0.00% over the past 1 year(s). The primary factor behind the change was an decrease in Unknown from 0.00 to 0.00.

The secondary factor is the Unknown, contributed 0.00% to the performance.

Overall, the performance of NVCR in the past 1 year(s) is driven by Unknown.

People Also Watch

Frequently Asked Questions

Is NVCR currently overvalued or undervalued?

What is Novocure Ltd (NVCR) fair value?

NVCR's fair value is calculated using relative valuation, based on historical P/E and P/S ranges and their premiums/discounts relative to a competitor average, adjusted by weights. The fair price of Novocure Ltd (NVCR) is between 86.79 to 166.21 according to relative valuation method.

How does NVCR's valuation metrics compare to the industry average?

The average P/S ratio for NVCR's competitors is 64.55, providing a benchmark for relative valuation. Novocure Ltd Corp (NVCR) exhibits a P/S ratio of 2.14, which is -96.68% above the industry average. Given its robust revenue growth of 8.11%, this premium appears unsustainable.

What is the current P/B ratio for Novocure Ltd (NVCR) as of Mar 26 2026?

As of Mar 26 2026, Novocure Ltd (NVCR) has a P/B ratio of 4.30. This indicates that the market values NVCR at 4.30 times its book value.

What is the current FCF Yield for Novocure Ltd (NVCR) as of Mar 26 2026?

As of Mar 26 2026, Novocure Ltd (NVCR) has a FCF Yield of -4.44%. This means that for every dollar of Novocure Ltd's market capitalization, the company generates -4.44 cents in free cash flow.

What is the current Forward P/E ratio for Novocure Ltd (NVCR) as of Mar 26 2026?

As of Mar 26 2026, Novocure Ltd (NVCR) has a Forward P/E ratio of -8.92. This means the market is willing to pay $-8.92 for every dollar of Novocure Ltd's expected earnings over the next 12 months.

What is the current Forward P/S ratio for Novocure Ltd (NVCR) as of Mar 26 2026?

As of Mar 26 2026, Novocure Ltd (NVCR) has a Forward P/S ratio of 2.14. This means the market is valuing NVCR at $2.14 for every dollar of expected revenue over the next 12 months.

NVCR Valuation